Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

Working at C4 Therapeutics

Zippia score 3.9

Overview

JobsSalaryRevenue

Reviews

CompetitorsCEO & Executives

C4 Therapeutics overview

Industry
Biotechnology
Revenue
$35.6M
Headquarters
Employees
300
Founded in
Website
Organization type
Public
Social media
C4 is building on the knowledge with synthetic chemical compounds which it calls Degronimids. These compounds can be engineered and linked together to bind with many molecular targets that today's drugs can't bind with, Cohen said. The key insight, he said, is that the scientific founders have discovered a way to bind with select disease-causing proteins, and flag them as cellular trash, so that the ordinary proteasome garbage disposal system can get rid of them. Selecting the precise disease-related proteins to send to the trash is obviously critical, because any drug like this could cause serious side effects if it sent healthy proteins involved in normal cell processes to the trash. C4 Therapeutics is developing a new class of targeted protein degradation (TPD) therapeutics for the treatment of a broad range of diseases. Our Degronimid™ platform incorporates highly selective small molecule binders to target disease-causing proteins and facilitate their rapid destruction and clearance from the cell through the natural ubiquitin/proteasome system (UPS). Because of this distinctive mechanism, Degronimids are capable of hitting many more targets, including those previously thought to be undruggable, while reducing the potential for drug resistance. The broad applicability of Degronimids, and our chemical biology platform designed for accelerated validation, have the potential to make an unprecedented impact across many diseases through multiple industry collaborations as well as proprietary programs. The Company has received an exclusive worldwide license to the Degronimid platform and related IP from Dana-Farber.
C4 Therapeutics is a medium health care company with 300 employees and an annual revenue of $35.6M that is headquartered in Cambridge, MA.

C4 Therapeutics's mission statement

To transforming the treatment of cancer and other diseases through the delivery of high-quality, safe, and effective novel therapies that eliminate disease-causing proteins.

In demand companies are hiring! Let Zippi apply for you!

Floating question marks illustration
-

C4 Therapeutics employee reviews

Be the first to review!

Do you work at C4 Therapeutics?

Help job seekers learn about working at C4 Therapeutics

Job openings at C4 Therapeutics
3 positions
See all jobs

On this page

Be the first to review C4 Therapeutics

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at C4 Therapeutics?

The team at C4 Therapeutics

  • The founders of C4 Therapeutics are Marc A. Cohen, Kenneth C. Anderson, Jay Bradner and Nathanael Gray.
  • The key people at C4 Therapeutics are Marc A. Cohen, Kenneth C. Anderson and Jay Bradner.
Key people
Marc A. Cohen
Kenneth C. Anderson
Jay Bradner
Nathanael Gray

C4 Therapeutics salaries

Average C4 Therapeutics salary
$79,232
yearly
$38.09 hourly
Updated March 14, 2024

Rate C4 Therapeutics' fairness in compensating employees.

Zippia waving zebra

Do you work at C4 Therapeutics?

Does C4 Therapeutics actively promote diversity and inclusion?

C4 Therapeutics financial performance

5.8
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

C4 Therapeutics currently has 31.1M in revenue. C4 Therapeutics's most recent quarter produced 11.1m (q3'2023).

C4 Therapeutics annual revenue

$46M
$37M
$27M
$18M
$9M
$0
2019
2020
2021
2022
2023
2024

Are you an executive, HR leader, or brand manager at C4 Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

C4 Therapeutics FAQs

Have more questions? See all answers to common company questions.

Search for jobs

Related companies

Cities with C4 Therapeutics jobs

Related companies

Related company jobs

    Updated March 14, 2024

    Zippia gives an in-depth look into the details of C4 Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about C4 Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at C4 Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by C4 Therapeutics. The data presented on this page does not represent the view of C4 Therapeutics and its employees or that of Zippia.

    C4 Therapeutics may also be known as or be related to C4 THERAPEUTICS, INC., C4 Therapeutics and C4 Therapeutics, Inc.